Johnson & Johnson Gets FDA OK To Market Carotid Artery Treatment
CHICAGO, Sept 26 (Reuters) - Johnson & Johnson (JNJ.N: Quote, Profile, Research) said on Tuesday U.S. regulators have approved its treatment for clogged neck arteries, a condition that could lead to stroke.